Systemic Lupus Erythematosus and Cardiovascular Disease

Area of Science:

• Immunology
• Rheumatology
• Cardiology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease causing inflammation across multiple organs.
• SLE disproportionately affects women of reproductive age, with a female-to-male ratio up to 13:1.
• SLE is linked to accelerated atherosclerosis and a higher risk of cardiovascular events like coronary artery disease (CAD).

Purpose of the Study:

• To explore the intricate relationship between SLE and cardiovascular disease (CVD).
• To elucidate the pathophysiological mechanisms linking SLE to CVD.
• To outline screening criteria and treatment strategies for CVD in SLE patients.

Main Methods:

• This review synthesizes existing literature on SLE and CVD.
• It examines immunological, endothelial, and vascular factors contributing to atherosclerosis in SLE.
• The review discusses screening protocols and therapeutic interventions for CVD in the context of SLE.

Main Results:

• SLE involves impaired immune regulation, endothelial cell function, and vascular repair, alongside hyperleptinemia and traditional risk factors, promoting early atherosclerosis.
• Cardiovascular events, including CAD, PAD, and CVA, are significantly elevated in SLE patients, often occurring at younger ages.
• Younger SLE patients face a disproportionately higher risk of CAD compared to age-matched individuals without SLE.

Conclusions:

• Understanding the link between SLE and CVD is critical for comprehensive patient management.
• Implementing specific screening criteria and tailored treatment plans can mitigate cardiovascular risks in SLE.
• Further research into SLE-specific CVD pathways may lead to improved patient outcomes.